BMA vs IFS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 08, 2026

BMA

53.4
AI Score
VS
BMA Wins

IFS

52.8
AI Score

Investment Advisor Scores

BMA

53score
Recommendation
BUY

IFS

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BMA IFS Winner
Forward P/E 3.0979 0 Tie
PEG Ratio 0.4681 0 Tie
Revenue Growth 21.4% 3.8% BMA
Earnings Growth 28.2% 2.4% BMA
Tradestie Score 53.4/100 52.8/100 BMA
Profit Margin 8.4% 35.7% IFS
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD BMA

Relative Price Performance (Last 90 Days)

BMA 1M: -2.5% · 3M: -20.5% IFS 1M: -0.3% · 3M: -0.9%

Current Technical Phase

BMA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.6%), weak momentum, RSI 43

RSI (14): 43.1 · Price: $77.82

IFS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.1 · Price: $54.73

Fundamentals Snapshot

Metric BMA IFS
Market Cap
Forward P/E 0.0 2.3
Trailing P/E 20.0 10.1
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin 0.3% 0.4%
EPS 3.94 5.43
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, BMA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.